Jefferies Group’s Translate Bio, Inc. Common Stock TBIO Stock Holding History

Jefferies Group’s Portfolio TBIO Stock Details TBIO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q3	–	Sell	-50,200	Closed	-$1.38M	–	2196
2021 Q2	$1.38M	Buy	+50,200	New	+$987K	0.01%	874
2020 Q3	–	Sell	-31,590	Closed	-$566	–	1641
2020 Q2	$566	Buy	+31,590	New	+$476K	0.01%	884

Jefferies Group's TBIO Position: Q3 2021 in Review

Jefferies Group sold out of Translate Bio, Inc. Common Stock (TBIO) in Q3 2021, closing a stake of 50,200 shares — an estimated $1.38M sold.

Jefferies Group first reported a position in TBIO in Q2 2020 and held it in 2 quarters. The position peaked at $1.38M in Q2 2021. 0 funds tracked by Wall St. Rank hold TBIO as of Q3 2021.

Jefferies Group reported no remaining Translate Bio, Inc. Common Stock position as of Q3 2021 after selling out during the quarter.
Jefferies Group sold 50,200 Translate Bio, Inc. Common Stock shares in Q3 2021, an estimated $1.38M.
Jefferies Group first reported a position in Translate Bio, Inc. Common Stock in Q2 2020 and held it in 2 quarters.
Jefferies Group's Translate Bio, Inc. Common Stock position peaked at $1.38M in Q2 2021.
0 funds tracked by Wall St. Rank held Translate Bio, Inc. Common Stock as of Q3 2021.

Based on Jefferies Group's 13F filing for Q3 2021, filed 15 Nov 2021.